Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Autonomix MedicalAMIX -12.48%15 Net Current Asset Value is $10.82 as of Mar. 2026, which is 1324% above its 10-year median of 0.76. GuruFocus rates AMIX with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Autonomix Medical ranks better than 98.42% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Autonomix Medical's net current asset value per share for the quarter that ended in Mar. 2026 was $10.82.
The historical rank and industry rank for Autonomix Medical's Net Current Asset Value or its related term are showing as below:
AMIX'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.53 Med: 0.76 Max: 7.5
Current: 0.53
During the past 4 years, the highest Price-to-Net-Current-Asset-Value Ratio of Autonomix Medical was 7.50. The lowest was 0.53. And the median was 0.76.
AMIX's Price-to-Net-Current-Asset-Value is ranked better than 98.42% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 4.91
vs AMIX: 0.53
Autonomix Medical (NAS:AMIX) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Autonomix Medical Net Current Asset Value Related Terms
Autonomix Medical Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Autonomix Medical's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMIX vs BJDX, LUDG, ALURD: Net Current Asset Value Comparison
For the Medical Devices subindustry, Autonomix Medical's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Autonomix Medical Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Autonomix Medical's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Autonomix Medical's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $10.82 mean?
Autonomix Medical (AMIX) has a Net Current Asset Value of $10.82 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Autonomix Medical and its competitors. This is 1324% above median its historical median of 0.76. Over the past decade, Autonomix Medical's Net Current Asset Value has ranged from 0.53 to 7.50. According to the industry distribution chart, Autonomix Medical ranks #9 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 1.6%.
Is Autonomix Medical's Net Current Asset Value too high?
Autonomix Medical's current Net Current Asset Value of $10.82 is 1324% above median its 10-year median of 0.76. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 7.50. The Medical Devices & Instruments industry median Net Current Asset Value is 4.91. Autonomix Medical's value of $10.82 is 120.4% above this industry median. Based on the distribution chart, Autonomix Medical ranks #9 out of 569 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Autonomix Medical has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Autonomix Medical's Net Current Asset Value compare to BJDX and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Autonomix Medical ranks #9 out of 569 companies for Net Current Asset Value. This places Autonomix Medical in the top 2% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 4.91. Autonomix Medical's value of $10.82 is 120.4% above this benchmark. Historically, Autonomix Medical's own Net Current Asset Value has ranged from 0.53 to 7.50 over the past decade. While the company's 10-year median is 0.76 vs. the industry median of 4.91, Autonomix Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.91, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Autonomix Medical's current Net Current Asset Value of $10.82 is 120.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Autonomix Medical and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Autonomix Medical's current Net Current Asset Value is $10.82, which is 1324% above median its own 10-year median of 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Autonomix Medical stock overvalued right now?
Autonomix Medical (AMIX) has a current Net Current Asset Value of $10.82. The current Net Current Asset Value is $10.82, which is 1324% above median its 10-year median of 0.76 and 120.4% above the Medical Devices & Instruments industry median of 4.91. Autonomix Medical's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Autonomix Medical (AMIX), the current Net Current Asset Value is $10.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
15GF Score
Get the complete analysis for AMIX
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMIX has been successfully added to your 
